Adam Mullick, Ph.D.
- Apr 12, 2017
- Topic: “RNA therapeutic drug discovery: Case Studies of targets in clinical and preclinical development"
- Date: Wednesday, November 8th 2017
- Time: 12:00pm
- Place: B448 Life Science Bldg
Recent advances in antisense oligonucleotide chemistry and delivery have established this platform as an exciting new therapeutic modality. Examples of target development of projects will be discussed, with examples of programs recently advanced into Phase 1 clinical trials and programs in pre-IND studies.